Ikarian Capital’s Autonomix Medical AMIX Stock Holding History

Ikarian Capital’s Portfolio AMIX Stock Details AMIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-890	Closed	-$7.29K	–	196
2026 Q1	$7.29K	Hold	890	–	–	﹤0.01%	161
2025 Q4	$10.3K	Sell	890 -62	-7%	-$1.2K	﹤0.01%	174
2025 Q3	$21.6K	Hold	952	–	–	﹤0.01%	169
2025 Q2	$31.4K	Hold	952	–	–	0.01%	130
2025 Q1	$35K	Hold	952	–	–	﹤0.01%	157
2024 Q4	$75.2K	Buy	+952	New	+$168K	0.01%	157

Other funds holding AMIX

Mariner Overland Park, Kansas $95.2B AUM 32.92% 1-Year Est. Return

APW

Allied Private Wealth Boca Raton, Florida $156M AUM

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

IRC

Investors Research Corp Atlanta, Georgia $559M AUM 21.55% 1-Year Est. Return

Networth Advisors Canonsburg, Pennsylvania $172M AUM

Ikarian Capital's AMIX Position: Q2 2026 in Review

Ikarian Capital sold out of Autonomix Medical (AMIX) in Q2 2026, closing a stake of 890 shares — an estimated $7.29K sold.

Ikarian Capital first reported a position in AMIX in Q4 2024 and held it in 6 quarters. The position peaked at $75.2K in Q4 2024. 6 funds tracked by Wall St. Rank hold AMIX as of Q2 2026.

Ikarian Capital reported no remaining Autonomix Medical position as of Q2 2026 after selling out during the quarter.
Ikarian Capital sold 890 Autonomix Medical shares in Q2 2026, an estimated $7.29K.
Ikarian Capital first reported a position in Autonomix Medical in Q4 2024 and held it in 6 quarters.
Ikarian Capital's Autonomix Medical position peaked at $75.2K in Q4 2024.
6 funds tracked by Wall St. Rank held Autonomix Medical as of Q2 2026.

Based on Ikarian Capital's 13F filing for Q2 2026, filed 14 Aug 2026.